Chandler, Kevin Brown <br/><br/>
β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma.  [electronic resource] 

 -  Molecular omics  06 2020 
 - 195-209 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2515-4184 
<br/><br/><label>Standard No.: </label>10.1039/d0mo00009d  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Binding Sites<br/>Bridged Bicyclo Compounds, Heterocyclic--administration & dosage<br/>CREB-Binding Protein--metabolism<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cell Line, Tumor<br/>ErbB Receptors--chemistry<br/>Fucose--metabolism<br/>Fucosyltransferases--genetics<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Mice<br/>Models, Molecular<br/>Mouth Neoplasms--drug therapy<br/>Neoplasm Metastasis<br/>Polysaccharides--metabolism<br/>Protein Structure, Tertiary<br/>Pyrimidinones--administration & dosage<br/>Small Molecule Libraries--administration & dosage<br/>Wnt Signaling Pathway--drug effects<br/>Xenograft Model Antitumor Assays<br/>beta Catenin--metabolism<br/>Galactoside 2-alpha-L-fucosyltransferase